183 related articles for article (PubMed ID: 35212788)
1. Preparation and In Vitro and In Vivo Evaluation of a Testosterone Film Forming Gel for the Treatment of Hypoactive Sexual Desire Disorder in Women.
Zeng J; Xie TF; Huang T; Li F; Wang ZP; Feng LL
AAPS PharmSciTech; 2022 Feb; 23(3):79. PubMed ID: 35212788
[TBL] [Abstract][Full Text] [Related]
2. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel soft hydrogel for the transdermal delivery of testosterone.
An NM; Kim DD; Shin YH; Lee CH
Drug Dev Ind Pharm; 2003 Jan; 29(1):99-105. PubMed ID: 12602497
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations.
Mura P; Faucci MT; Bramanti G; Corti P
Eur J Pharm Sci; 2000 Feb; 9(4):365-72. PubMed ID: 10664476
[TBL] [Abstract][Full Text] [Related]
5. Possibilities of the microemulsion use as indomethacin solubilizer and its effect on
Špaglová M; Čuchorová M; Šimunková V; Matúšová D; Čierna M; Starýchová L; Bauerová K
Drug Dev Ind Pharm; 2020 Sep; 46(9):1468-1476. PubMed ID: 32715801
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of ketorolac.
Amrish C; Kumar SP
Yakugaku Zasshi; 2009 Mar; 129(3):373-9. PubMed ID: 19252396
[TBL] [Abstract][Full Text] [Related]
7. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use.
Amnuaikit C; Ikeuchi I; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2005 Jan; 289(1-2):167-78. PubMed ID: 15652209
[TBL] [Abstract][Full Text] [Related]
8. Effect of sonophoresis and chemical enhancers on testosterone transdermal delivery from solid lipid microparticles: an in vitro study.
El-Kamel AH; Al-Fagih IM; Alsarra IA
Curr Drug Deliv; 2008 Jan; 5(1):20-6. PubMed ID: 18220547
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
10. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
11. Effect of chemical enhancers in transdermal permeation of alfuzosin hydrochloride.
Prasanthi D; Lakshmi PK
ISRN Pharm; 2012; 2012():965280. PubMed ID: 23316394
[TBL] [Abstract][Full Text] [Related]
12. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
[TBL] [Abstract][Full Text] [Related]
15. Enhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with transcutol P.
Lee SG; Kang JB; Kim SR; Kim CJ; Yeom DW; Yoon HY; Kwak SS; Choi YW
Drug Dev Ind Pharm; 2016 Oct; 42(10):1636-42. PubMed ID: 26925849
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies.
Panchagnula R; Ritschel WA
J Pharm Pharmacol; 1991 Sep; 43(9):609-14. PubMed ID: 1685517
[TBL] [Abstract][Full Text] [Related]
17. Formulation of a reservoir-type testosterone transdermal delivery system.
Kim MK; Zhao H; Lee CH; Kim DD
Int J Pharm; 2001 May; 219(1-2):51-9. PubMed ID: 11337165
[TBL] [Abstract][Full Text] [Related]
18. Effects of vehicles and enhancers on transdermal delivery of clebopride.
Rhee YS; Huh JY; Park CW; Nam TY; Yoon KR; Chi SC; Park ES
Arch Pharm Res; 2007 Sep; 30(9):1155-61. PubMed ID: 17958335
[TBL] [Abstract][Full Text] [Related]
19. New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin.
Nicoli S; Penna E; Padula C; Colombo P; Santi P
Int J Pharm; 2006 Nov; 325(1-2):2-7. PubMed ID: 16860952
[TBL] [Abstract][Full Text] [Related]
20. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
